Cannibals At The Gates Of Congress: A Call For Activism, Not Complacency

"Cannibals" At The Gates Of Congress: A Call For Activism, Not Complacency The Scientist, Vol:10, #4, pg.10 , February 19, 1996. Author: Eugene Garfield       There was an audible sigh of relief in the life sciences community in early January when Congress approved-and President Clinton signed-authorization bill H.R. 1358. The bill set the fiscal year 1996 budget of the National Institutes of Health at $11.9 billion, an increase of 5.7 percent. With the Republicans in Congre

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Other science funding agencies have not fared as well. Under an omnibus bill (H.R. 2405) passed last October that combined authorizations for seven federal funding agencies, the total appropriations for basic research increased by just 1.4 percent. The loser was the National Science Foundation, which took a cut of 0.8 percent, from $2.245 billion in 1995 to $2.226 billion in 1996. However, the bill is still pending in the Senate.

These modest increases are welcome news to the scientific community, in light of earlier threats by freshman members of Congress to slash science funding by 30 percent over the next seven years. But it would be a serious mistake for scientists to become-or remain-complacent about congressional research funding decisions.

The need for activism was best expressed by House Science Committee Chairman Robert S. Walker (R-Pa.). In a House debate on July 12 about an energy and water appropriation bill (H.R. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo